Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine whether "on-demand" sildenafil is effective in the treatment of Raynaud's phenomenon.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02050360
Study type Interventional
Source University Hospital, Grenoble
Contact
Status Completed
Phase Phase 2/Phase 3
Start date November 2013
Completion date May 2015

See also
  Status Clinical Trial Phase
Completed NCT00946738 - The Effect of Physical Therapy on Raynaud`s Phenomenon Secondary to Systemic Sclerosis N/A
Completed NCT01117298 - A Randomized Control Trial to Assess the Efficacy of Tadalafil in Raynaud's Phenomenon in Scleroderma Phase 3
Completed NCT02583789 - Assess Efficacy of of Oral Treprostinil in Patients With Symptomatic Primary or Secondary Raynaud's Phenomenon Early Phase 1
Terminated NCT01315899 - Efficacy of ORM-12741 for Prevention of Raynaud's Phenomenon Phase 2
Completed NCT03058887 - The Effects of Exercise in Patients With Systemic Sclerosis N/A
Completed NCT00700518 - Dose Response to Topical Glyceryl Trinitrate in Patients With Raynaud's Phenomenon Phase 1
Completed NCT02506062 - A Trial of Ischemic Preconditioning in Raynaud's Phenomenon (RP) N/A
Recruiting NCT01378845 - Prognostic Influence of Light Rheography Measurement of Patients With Secondary Raynaud Syndrome With Ulcers on Hands N/A
Completed NCT00841594 - MQX-503 Applied to the Hand Versus Nitroglycerin Ointment Applied to the Chest: A Pharmacokinetic Comparison Phase 1